Functional dichotomy in natural killer cell signaling: Vav1-dependent and -independent mechanisms.

The product of the protooncogene Vav1 participates in multiple signaling pathways and is a critical regulator of antigen–receptor signaling in B and T lymphocytes, but its role during in vivo natural killer (NK) cell differentiation is not known. Here we have studied NK cell development in Vav1−/− mice and found that, in contrast to T and NK-T cells, the absolute numbers of phenotypically mature NK cells were not reduced. Vav1−/− mice produced normal amounts of interferon (IFN)-γ in response to Listeria monocytogenes and controlled early infection but showed reduced tumor clearance in vivo. In vitro stimulation of surface receptors in Vav1−/− NK cells resulted in normal IFN-γ production but reduced tumor cell lysis. Vav1 was found to control activation of extracellular signal-regulated kinases and exocytosis of cytotoxic granules. In contrast, conjugate formation appeared to be only mildly affected, and calcium mobilization was normal in Vav1−/− NK cells. These results highlight fundamental differences between proximal signaling events in T and NK cells and suggest a functional dichotomy for Vav1 in NK cells: a role in cytotoxicity but not for IFN-γ production.

[1]  L. Eisenlohr,et al.  Differential Role of p38 and c-Jun N-Terminal Kinase 1 Mitogen-Activated Protein Kinases in NK Cell Cytotoxicity1 , 2000, The Journal of Immunology.

[2]  P. Leibson,et al.  The Rho Family Guanine Nucleotide Exchange Factor Vav-2 Regulates the Development of Cell-Mediated Cytotoxicity , 2000, The Journal of experimental medicine.

[3]  J. Cleveland,et al.  Phospholipase Cgamma2 is essential in the functions of B cell and several Fc receptors. , 2000, Immunity.

[4]  B. Pulendran,et al.  Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. , 2000, Blood.

[5]  R. Biassoni,et al.  Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis. , 2000, Immunology today.

[6]  P. Morrissey,et al.  Reversible Defects in Natural Killer and Memory Cd8 T Cell Lineages in Interleukin 15–Deficient Mice , 2000, The Journal of experimental medicine.

[7]  P. Berche,et al.  The ClpP serine protease is essential for the intracellular parasitism and virulence of Listeria monocytogenes , 2000, Molecular microbiology.

[8]  J. Trapani,et al.  Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells , 2000, The Journal of experimental medicine.

[9]  J. D. Di Santo,et al.  The receptor tyrosine kinase c-kit provides a critical signal for survival, expansion, and maturation of mouse natural killer cells. , 2000, Blood.

[10]  M. Turner,et al.  Redundant role of the Syk protein tyrosine kinase in mouse NK cell differentiation. , 1999, Journal of immunology.

[11]  K. Tedford,et al.  The oncogene product Vav is a crucial regulator of primary cytotoxic T cell responses but has no apparent role in CD28‐mediated co‐stimulation , 1999, European journal of immunology.

[12]  M. Turner,et al.  The Rho-family GTP exchange factor Vav is a critical transducer of T cell receptor signals to the calcium, ERK, and NF-kappaB pathways. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[13]  L. Frati,et al.  Role for the Rac1 exchange factor Vav in the signaling pathways leading to NK cell cytotoxicity. , 1999, Journal of immunology.

[14]  J. D. Di Santo,et al.  Dissecting NK cell development using a novel alymphoid mouse model: investigating the role of the c-abl proto-oncogene in murine NK cell differentiation. , 1999, Journal of immunology.

[15]  L. Eisenlohr,et al.  Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases. , 1998, Journal of immunology.

[16]  J. Penninger,et al.  Vav Regulates Peptide-specific Apoptosis in Thymocytes , 1998, The Journal of experimental medicine.

[17]  I. Puzanov,et al.  Natural killer cell differentiation: insights from knockout and transgenic mouse models and in vitro systems , 1998, Immunological reviews.

[18]  T. Ley,et al.  How do cytotoxic lymphocytes kill their targets? , 1998, Current opinion in immunology.

[19]  X. Bustelo,et al.  The Vav–Rac1 Pathway in Cytotoxic Lymphocytes Regulates the Generation of Cell-mediated Killing , 1998, The Journal of experimental medicine.

[20]  D. Cantrell Lymphocyte signalling: A coordinating role for Vav? , 1998, Current Biology.

[21]  Sebastian Amigorena,et al.  Deficient Peptide Loading and MHC Class II Endosomal Sorting in a Human Genetic Immunodeficiency Disease: the Chediak-Higashi Syndrome , 1998, The Journal of cell biology.

[22]  Jin Hong Liu,et al.  Control of Lytic Function by Mitogen-activated Protein Kinase/Extracellular Regulatory Kinase 2 (ERK2) in a Human Natural Killer Cell Line: Identification of Perforin and Granzyme B Mobilization by Functional ERK2 , 1998, The Journal of experimental medicine.

[23]  K. Tedford,et al.  Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor , 1998, Current Biology.

[24]  F. Alt,et al.  Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction , 1998, Current Biology.

[25]  D. Fearon,et al.  CD19 as a membrane-anchored adaptor protein of B lymphocytes: costimulation of lipid and protein kinases by recruitment of Vav. , 1998, Immunity.

[26]  J. Dorfman,et al.  Acquisition of Ly49 Receptor Expression by Developing Natural Killer Cells , 1998, The Journal of experimental medicine.

[27]  W. Yokoyama,et al.  NK cell granule exocytosis and cytokine production inhibited by Ly-49A engagement. , 1998, Cellular immunology.

[28]  M. White,et al.  Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav. , 1998, Science.

[29]  R. Zamoyska,et al.  A requirement for the Rho-family GTP exchange factor Vav in positive and negative selection of thymocytes. , 1997, Immunity.

[30]  P. Leibson Signal transduction during natural killer cell activation: inside the mind of a killer. , 1997, Immunity.

[31]  T. L. Collins,et al.  Views on Vav. , 1997, Immunology today.

[32]  L. Frati,et al.  CD16 cross-linking induces both secretory and extracellular signal-regulated kinase (ERK)-dependent cytosolic phospholipase A2 (PLA2) activity in human natural killer cells: involvement of ERK, but not PLA2, in CD16-triggered granule exocytosis. , 1997, Journal of immunology.

[33]  K. Schuebel,et al.  Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product , 1997, Nature.

[34]  M. Olson,et al.  Faciogenital dysplasia protein (FGD1) and Vav, two related proteins required for normal embryonic development, are upstream regulators of Rho GTPases , 1996, Current Biology.

[35]  T. Moore,et al.  Inhibition of gamma delta T cell development and early thymocyte maturation in IL-7 -/- mice. , 1996, Journal of immunology.

[36]  A. Chong,et al.  Vav in natural killer cells is tyrosine phosphorylated upon cross-linking of Fc gamma RIIIA and is constitutively associated with a serine/threonine kinase. , 1996, The Biochemical journal.

[37]  M. Barbacid,et al.  Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav. , 1996, Oncogene.

[38]  M. Lovett,et al.  Identification of the homologous beige and Chediak–Higashi syndrome genes , 1996, Nature.

[39]  M. Barbacid,et al.  Defective T-cell receptor signalling and positive selection of Vav-deficient CD4+CDS+thymocytes , 1995, Nature.

[40]  K. Rajewsky,et al.  Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav , 1995, Nature.

[41]  F. Alt,et al.  Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene , 1995, Nature.

[42]  R. Abraham,et al.  Fc receptor stimulation of phosphatidylinositol 3-kinase in natural killer cells is associated with protein kinase C-independent granule release and cell-mediated cytotoxicity , 1994, The Journal of experimental medicine.

[43]  L. Platanias,et al.  Interferon alpha induces rapid tyrosine phosphorylation of the vav proto-oncogene product in hematopoietic cells. , 1994, The Journal of biological chemistry.

[44]  I. Lemischka,et al.  Mitogenic signalling and substrate specificity of the Flk2/Flt3 receptor tyrosine kinase in fibroblasts and interleukin 3-dependent hematopoietic cells , 1993, Molecular and cellular biology.

[45]  M. Barbacid,et al.  Steel factor stimulates the tyrosine phosphorylation of the proto-oncogene product, p95vav, in human hemopoietic cells. , 1992, The Journal of biological chemistry.

[46]  Amos Bairoch,et al.  Proto-vav and gene expression , 1992, Nature.

[47]  T. Lints,et al.  The hematopoietically expressed vav proto-oncogene shares homology with the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24) involved in cytoskeletal organization. , 1992, Oncogene.

[48]  V. Stewart,et al.  RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement , 1992, Cell.

[49]  A. Ullrich,et al.  Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs , 1992, Nature.

[50]  M. Barbacid,et al.  Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates , 1992, Nature.

[51]  H. Ljunggren,et al.  Alteration of the natural killer repertoire in H-2 transgenic mice: specificity of rapid lymphoma cell clearance determined by the H-2 phenotype of the target , 1991, The Journal of experimental medicine.

[52]  E. Unanue,et al.  Regulation of gamma interferon production by natural killer cells in scid mice: roles of tumor necrosis factor and bacterial stimuli , 1991, Infection and immunity.

[53]  G. Trinchieri,et al.  Biology of Natural Killer Cells , 1989, Advances in Immunology.

[54]  M. Barbacid,et al.  vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells. , 1989, The EMBO journal.

[55]  H. Ljunggren,et al.  Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy , 1986, Nature.

[56]  C. Biron,et al.  Natural killer cells in antiviral defense: function and regulation by innate cytokines. , 1999, Annual review of immunology.

[57]  L. Lanier NK cell receptors. , 1998, Annual review of immunology.